MoonLake Immunotherapeutics (MLTX)
10.32
-0.45
(-4.18%)
USD |
NASDAQ |
Oct 08, 11:34
MoonLake Immunotherapeutics Net Income (Quarterly) : -61.80M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -61.80M |
| March 31, 2026 | -69.71M |
| December 31, 2025 | -63.02M |
| September 30, 2025 | -70.69M |
| June 30, 2025 | -56.05M |
| March 31, 2025 | -40.56M |
| December 31, 2024 | -46.40M |
| September 30, 2024 | -36.11M |
| June 30, 2024 | -24.76M |
| March 31, 2024 | -13.98M |
| December 31, 2023 | -7.887M |
| September 30, 2023 | -11.62M |
| Date | Value |
|---|---|
| June 30, 2023 | -12.35M |
| March 31, 2023 | -12.22M |
| December 31, 2022 | -16.47M |
| September 30, 2022 | -14.74M |
| June 30, 2022 | -17.42M |
| March 31, 2022 | -15.88M |
| December 31, 2021 | -14.32M |
| September 30, 2021 | -6.288M |
| June 30, 2021 | -32.69M |
| March 31, 2021 | -0.0763M |
| December 31, 2020 | -0.0858M |
| September 30, 2020 | -0.005M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 237.40M |
| AC Immune SA | 2.371M |
| CRISPR Therapeutics AG | -91.15M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 61.80M |
| EPS Diluted (Quarterly) | -0.8362 |
| Enterprise Value | 464.95M |
| Earnings Yield | -37.17% |
| Normalized Earnings Yield | -37.17 |